Singapore markets close in 2 hours 25 minutes
Straits Times Index
3,172.58 -15.08 (-0.47%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,194.84 -191.03 (-1.17%) FTSE 100
7,877.05 +29.06 (+0.37%) Bitcoin USD
62,215.91 +1,096.61 (+1.79%) CMC Crypto 200
1,279.59 -33.03 (-2.52%)
Allogene Therapeutics, Inc. (ALLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 583.37M |
| Enterprise value | 229.79M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.70k |
| Price/book (mrq) | 1.14 |
| Enterprise value/revenue | 2.42k |
| Enterprise value/EBITDA | -0.77 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.80 |
| 52-week change 3 | -36.04% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 6.8900 |
| 52-week low 3 | 2.2300 |
| 50-day moving average 3 | 4.4960 |
| 200-day moving average 3 | 3.7943 |
Share statistics
| Avg vol (3-month) 3 | 2.34M |
| Avg vol (10-day) 3 | 1.75M |
| Shares outstanding 5 | 169.09M |
| Implied shares outstanding 6 | 169.09M |
| Float 8 | 111M |
| % held by insiders 1 | 22.44% |
| % held by institutions 1 | 73.66% |
| Shares short (28 Mar 2024) 4 | 30.62M |
| Short ratio (28 Mar 2024) 4 | 11.76 |
| Short % of float (28 Mar 2024) 4 | 26.60% |
| Short % of shares outstanding (28 Mar 2024) 4 | 18.11% |
| Shares short (prior month 29 Feb 2024) 4 | 25.01M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 163,475.00% |
Management effectiveness
| Return on assets (ttm) | -26.84% |
| Return on equity (ttm) | -55.51% |
Income statement
| Revenue (ttm) | 95k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -300.29M |
| Net income avi to common (ttm) | -327.26M |
| Diluted EPS (ttm) | -2.0900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 448.7M |
| Total cash per share (mrq) | 2.65 |
| Total debt (mrq) | 95.12M |
| Total debt/equity (mrq) | 18.57% |
| Current ratio (mrq) | 12.38 |
| Book value per share (mrq) | 3.04 |
Cash flow statement
| Operating cash flow (ttm) | -237.73M |
| Levered free cash flow (ttm) | -134.26M |
© 2024 Yahoo. All rights reserved.